Scinai Immunotherapeutics (SCNI) Net Cash Flow Growth (3y) (2021 - 2026)
Scinai Immunotherapeutics (SCNI) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 32.17% |
| 10 | Scinai Immunotherapeutics | 3.93 Bn | 811.90 Mn | -1.12 Mn | 34.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.35% |
| Jun 30, 2025 | 73.55% |
| Mar 31, 2025 | 17.05% |
| Dec 31, 2024 | -49.32% |
| Sep 30, 2024 | 34.61% |
| Jun 30, 2024 | 40.49% |
| Mar 31, 2024 | -26.07% |
| Dec 31, 2023 | 54.89% |
| Sep 30, 2023 | 45.43% |
| Jun 30, 2023 | -1.49% |
| Dec 31, 2022 | -27.44% |
| Sep 30, 2022 | -26.60% |
| Mar 31, 2022 | 29.29% |
| Mar 31, 2021 | 64.69% |